Cargando…
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal fibrosing lung disease of unknown cause. The advent of anti-fibrotic medications known to slow disease progression has revolutionised IPF management in recent years. However, little is known about the natural history of IPF p...
Autores principales: | Jo, Helen E., Glaspole, Ian, Moodley, Yuben, Chapman, Sally, Ellis, Samantha, Goh, Nicole, Hopkins, Peter, Keir, Greg, Mahar, Annabelle, Cooper, Wendy, Reynolds, Paul, Haydn Walters, E., Zappala, Christopher, Grainge, Christopher, Allan, Heather, Macansh, Sacha, Corte, Tamera J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785886/ https://www.ncbi.nlm.nih.gov/pubmed/29370786 http://dx.doi.org/10.1186/s12890-018-0575-y |
Ejemplares similares
-
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019) -
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
por: Cox, Ingrid A., et al.
Publicado: (2022) -
There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)
por: Nambiar, Shabarinath, et al.
Publicado: (2021) -
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
por: Cox, Ingrid A., et al.
Publicado: (2022) -
Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective
por: Teoh, Alan K. Y., et al.
Publicado: (2020)